The complement system in COVID-19: friend and foe?
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in a global pandemic and a disruptive health crisis. COVID-19-related morbidity and mortality have been attributed to an exaggerated immune response. The role of complement activation and its contribution to illness severity is being increasingly recognized. Here, we summarize current knowledge about the interaction of coronaviruses with the complement system. We posit that (a) coronaviruses activate multiple complement pathways; (b) severe COVID-19 clinical features often resemble complementopathies; (c) the combined effects of complement activation, dysregulated neutrophilia, endothelial injury, and hypercoagulability appear to be intertwined to drive the severe features of COVID-19; (d) a subset of patients with COVID-19 may have a genetic predisposition associated with complement dysregulation; and (e) these observations create a basis for clinical trials of complement inhibitors in life-threatening illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“Complement activation has been described in severe cases, and an admission D-dimer level >1 μg/L predicts an 18-fold increase of in-hospital mortality (58).”
BackgroundWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166 · cited 1×
“manifestations are more frequent than hemorrhage (63).”
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171 · cited 4×
“As has been widely reported from data sets from China (36), Italy (37), and the United States (38, 39), the case fatality rate of COVID-19 rises with age.”
BackgroundInfluentialCRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Boundy, E., Bowen, V., Chow, N., Cohn, A., Dowling, N., Ellington, S., Gierke, R., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6912e2 · Cited by 2,277
Magro, C., Mulvey, J. J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A., & Laurence, J. (2020) · Translational Research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,183
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179 · cited 2×
“These reports, in combination with results from both targeted and unbiased proteomic studies, have increased the likelihood that complement activation is a key contributor to the COVID-19 pathogenesis (12-17).”
BackgroundResultLarge-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Multiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“This may be a result of the broad organ tropism of SARS-CoV-2 (46) and resultant damage induced by both the virus and the immune response to it, which is especially true in the lung.”
BackgroundRenal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Su, H., Yang, M., Wan, C., Yi, L.-X., Tang, F., Zhu, H.-Y., Yi, F., Yang, H.-C., Fogo, A. B., Nie, X., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.003 · Cited by 1,755
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Quincy Brown, J., & Vander Heide, R. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,526
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.032 · Cited by 1,514
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.-M., Divatia, J. V., Shrestha, B. R., Arabi, Y. M., Ng, J., Gomersall, C. D., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30161-2 · Cited by 1,509
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486
Di Mascio, D., Khalil, A., Saccone, G., Rizzo, G., Buca, D., Liberati, M., Vecchiet, J., Nappi, L., Scambia, G., Berghella, V., et al. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100107 · Cited by 1,316
Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., Pesenti, A., Peyvandi, F., & Tripodi, A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14850 · Cited by 1,315
Pedersen, S. F., & Ho, Y.-C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137647 · Cited by 1,137 · cited 1×
“One such example is the rapid clinical deterioration in cardiorespiratory status, reminiscent of cytokine release syndrome (9-11).”
BackgroundManagement of COVID-19 Respiratory Distress
Marini, J. J., & Gattinoni, L. (2020) · JAMA · doi:10.1001/jama.2020.6825 · Cited by 1,100
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
Ranucci, M., Ballotta, A., Di Dedda, U., Baryshnikova, E., Dei Poli, M., Resta, M., Falco, M., Albano, G., & Menicanti, L. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14854 · Cited by 965
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility
Zhao, J., Yang, Y., Huang, H., Li, D., Gu, D., Lu, X., Zhang, Z., Liu, L., Liu, T., Liu, Y., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1150 · Cited by 853
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., van Buskirk, C., Grossman, B. J., Joyner, M., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 799
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Markiewski, M. M., & Lambris, J. D. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070166 · Cited by 722
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., Whitmore, A., Heise, M. T., & Baric, R. S. (2018) · mBio · doi:10.1128/mbio.01753-18 · Cited by 655
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
Batlle, D., Soler, M. J., Sparks, M. A., Hiremath, S., South, A. M., Welling, P. A., Swaminathan, S., & on behalf of the COVID-19 and ACE2 in Cardiovascular, L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040419 · Cited by 614
Cross Talk Pathways Between Coagulation and Inflammation
Foley, J. H., & Conway, E. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306853 · Cited by 589
Liszewski, M. K., Kolev, M., Le Friec, G., Leung, M., Bertram, P. G., Fara, A. F., Subias, M., Pickering, M. C., Drouet, C., Meri, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.018 · Cited by 582
Self-citationAssociations between blood type and COVID-19 infection, intubation, and death
Zietz, M., Zucker, J., & Tatonetti, N. P. (2020) · Nature Communications · doi:10.1038/s41467-020-19623-x · Cited by 581
Postmortem Examination of Patients With COVID-19
Schaller, T., Hirschbühl, K., Burkhardt, K., Braun, G., Trepel, M., Märkl, B., & Claus, R. (2020) · JAMA · doi:10.1001/jama.2020.8907 · Cited by 557
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4 + T cells
Arbore, G., West, E. E., Spolski, R., Robertson, A. A. B., Klos, A., Rheinheimer, C., Dutow, P., Woodruff, T. M., Yu, Z. X., O’Neill, L. A., et al. (2016) · Science · doi:10.1126/science.aad1210 · Cited by 513
Glowacka, I., Bertram, S., Herzog, P., Pfefferle, S., Steffen, I., Muench, M. O., Simmons, G., Hofmann, H., Kuri, T., Weber, F., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01248-09 · Cited by 495
NETosis, complement, and coagulation: a triangular relationship
de Bont, C. M., Boelens, W. C., & Pruijn, G. J. M. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-018-0024-0 · Cited by 492
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Complement as a target in COVID-19?
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 484
Angus, D. C., Berry, S., Lewis, R. J., Al-Beidh, F., Arabi, Y., van Bentum-Puijk, W., Bhimani, Z., Bonten, M., Broglio, K., Brunkhorst, F., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-192sd · Cited by 446
Severe COVID-19 infection associated with endothelial activation
Escher, R., Breakey, N., & Lämmle, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.014 · Cited by 441
Hattori, R., Hamilton, K. K., McEver, R. P., & Sims, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81901-9 · Cited by 438
Gao, T., Zhu, L., Liu, H., Zhang, X., Wang, T., Fu, Y., Li, H., Dong, Q., Hu, Y., Zhang, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01133-5 · Cited by 436
Lee, J. W., Sicre de Fontbrune, F., Wong Lee Lee, L., Pessoa, V., Gualandro, S., Füreder, W., Ptushkin, V., Rottinghaus, S. T., Volles, L., Shafner, L., et al. (2019) · Blood · doi:10.1182/blood-2018-09-876136 · Cited by 416
Guillon, P., Clément, M., Sébille, V., Rivain, J.-G., Chou, C.-F., Ruvoën-Clouet, N., & Le Pendu, J. (2008) · Glycobiology · doi:10.1093/glycob/cwn093 · Cited by 411
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience
Bryce, C., Grimes, Z., Pujadas, E., Ahuja, S., Beasley, M. B., Albrecht, R., Hernandez, T., Stock, A., Zhao, Z., AlRasheed, M. R., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00793-y · Cited by 405
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall, V., Thangaraj, P. M., Meydan, C., Foox, J., Butler, D., Kim, J., May, B., De Freitas, J. K., Glicksberg, B. S., Mason, C. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1021-2 · Cited by 351
ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome
(2005) · JAMA · doi:10.1001/jama.293.12.1450-c · Cited by 350
Folco, E. J., Mawson, T. L., Vromman, A., Bernardes-Souza, B., Franck, G., Persson, O., Nakamura, M., Newton, G., Luscinskas, F. W., & Libby, P. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311150 · Cited by 341
Diurno, F., Numis, F. G., Porta, G., Cirillo, F., Maddaluno, S., Ragozzino, A., Negri, P. D., Gennaro, C. D., Pagano, A., Allegorico, E., et al. (2020) · PubMed · doi:10.26355/eurrev_202004_20875 · Cited by 326
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Mastaglio, S., Ruggeri, A., Risitano, A. M., Angelillo, P., Yancopoulou, D., Mastellos, D. C., Huber-Lang, M., Piemontese, S., Assanelli, A., Garlanda, C., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108450 · Cited by 283
Genomic view of the evolution of the complement system
Nonaka, M., & Kimura, A. (2006) · Immunogenetics · doi:10.1007/s00251-006-0142-1 · Cited by 282
Complement and the Regulation of T Cell Responses
West, E. E., Kolev, M., & Kemper, C. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053245 · Cited by 269
Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2
Krarup, A., Wallis, R., Presanis, J. S., Gál, P., & Sim, R. B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000623 · Cited by 262
Complement and viral pathogenesis
Stoermer, K. A., & Morrison, T. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.045 · Cited by 255
Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions
Michiels, C., Arnould, T., & Remacle, J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00041-0 · Cited by 253
Subramaniam, S., Jurk, K., Hobohm, L., Jäckel, S., Saffarzadeh, M., Schwierczek, K., Wenzel, P., Langer, F., Reinhardt, C., & Ruf, W. (2017) · Blood · doi:10.1182/blood-2016-11-749879 · Cited by 251
Complement activation in patients with COVID-19: A novel therapeutic target
Cugno, M., Meroni, P. L., Gualtierotti, R., Griffini, S., Grovetti, E., Torri, A., Panigada, M., Aliberti, S., Blasi, F., Tedesco, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.006 · Cited by 247
Socié, G., Caby‐Tosi, M., Marantz, J. L., Cole, A., Bedrosian, C. L., Gasteyger, C., Mujeebuddin, A., Hillmen, P., Vande Walle, J., & Haller, H. (2019) · British Journal of Haematology · doi:10.1111/bjh.15790 · Cited by 239
A phylogenomic data-driven exploration of viral origins and evolution
Nasir, A., & Caetano-Anollés, G. (2015) · Science Advances · doi:10.1126/sciadv.1500527 · Cited by 212
Intracellular complement − the complosome − in immune cell regulation
Arbore, G., Kemper, C., & Kolev, M. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.012 · Cited by 210
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
Ghebrehiwet, B., Randazzo, B. P., Dunn, J. T., Silverberg, M., & Kaplan, A. P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110898 · Cited by 196
Intracellular sensing of complement C3 activates cell autonomous immunity
Tam, J. C. H., Bidgood, S. R., McEwan, W. A., & James, L. C. (2014) · Science · doi:10.1126/science.1256070 · Cited by 189
Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily
Gavriilaki, E., & Brodsky, R. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16783 · Cited by 178
Renal proximal tubular AT2 receptor: signaling and transport.
Haithcock, D., Jiao, H., Cui, X. L., Hopfer, U., & Douglas, J. G. (1999) · PubMed · Cited by 177
Xiong, M., Liang, X., & Wei, Y. (2020) · British Journal of Haematology · doi:10.1111/bjh.16725 · Cited by 174
Complement Evasion Strategies of Viruses: An Overview
Agrawal, P., Nawadkar, R., Ojha, H., Kumar, J., & Sahu, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01117 · Cited by 173
Localization of the complement regulatory proteins in the normal human kidney
Ichida, S., Yuzawa, Y., Okada, H., Yoshioka, K., & Matsuo, S. (1994) · Kidney International · doi:10.1038/ki.1994.247 · Cited by 165
Compendium of current complement therapeutics
Zelek, W. M., Xie, L., Morgan, B. P., & Harris, C. L. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.030 · Cited by 163
Thrombotic microangiopathy in a patient with COVID-19
Jhaveri, K. D., Meir, L. R., Chang, B. S. F., Parikh, R., Wanchoo, R., Barilla-LaBarca, M.-L., Bijol, V., & Hajizadeh, N. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.025 · Cited by 144
Kallikrein Cleaves C3 and Activates Complement
Irmscher, S., Döring, N., Halder, L. D., Jo, E. A. H., Kopka, I., Dunker, C., Jacobsen, I. D., Luo, S., Slevogt, H., Lorkowski, S., et al. (2018) · Journal of Innate Immunity · doi:10.1159/000484257 · Cited by 141
Heparan sulfate as a regulator of inflammation and immunity
Collins, L. E., & Troeberg, L. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0618-246r · Cited by 141
The role of C5a and antibody in the release of heparan sulfate from endothelial cells
Platt, J. L., Dalmasso, A. P., LINDMAN, B. J., Ihrcke, N. S., & Bach, F. H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211135 · Cited by 133
Complement Activation in Angiotensin II–Induced Organ Damage
Shagdarsuren, E., Wellner, M., Braesen, J.-H., Park, J.-K., Fiebeler, A., Henke, N., Dechend, R., Gratze, P., Luft, F. C., & Muller, D. N. (2005) · Circulation Research · doi:10.1161/01.res.0000182677.89816.38 · Cited by 128
Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age
Rodríguez‐Zhurbenko, N., Quách, T. D., Hopkins, T. J., Rothstein, T. L., & Hernández, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00483 · Cited by 123
A C3(H20) recycling pathway is a component of the intracellular complement system
Elvington, M., Liszewski, M. K., Bertram, P., Kulkarni, H. S., & Atkinson, J. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89412 · Cited by 115
Self-citationTimmermans, S. A. M. E. G., Hamid, M. A. A., Potjewijd, J., Theunissen, R. O. M. F. I. H., Damoiseaux, J. G. M. C., Reutelingsperger, C. P. M., van Paassen, P., & on behalf of the Limburg Renal Registry (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018020184 · Cited by 108
Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death
Kulkarni, H. S., Elvington, M. L., Perng, Y.-C., Liszewski, M. K., Byers, D. E., Farkouh, C. S., Yusen, R. D., Lenschow, D. J., Brody, S. L., & Atkinson, J. P. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0405oc · Cited by 105
Self-citationRipoche, J., Mitchell, J. A., Erdei, A., Madin, C., Moffatt, B. E., Mokoena, T., Gordon, S., & Sim, R. B. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.5.1917 · Cited by 101
Apical Proteins Stimulate Complement Synthesis by Cultured Human Proximal Tubular Epithelial Cells
Tang, S. C. W., Sheerin, N., Zhou, W., Brown, Z., & Sacks, S. H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10169 · Cited by 100
Complement Dysregulation and Disease: Insights from Contemporary Genetics
Liszewski, M. K., Java, A., Schramm, E. C., & Atkinson, J. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044145 · Cited by 99
Self-citationEllinghaus, D., Degenhardt, F. C., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., Fernández, J., Prati, D., Baselli, G., Asselta, R., et al. (2020) · medRxiv · doi:10.1101/2020.05.31.20114991 · Cited by 95
Platelet Mediated Complement Activation
Peerschke, E. I. B., Yin, W., & Ghebrehiwet, B. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_7 · Cited by 93
Sun, S., Zhao, G., Liu, C., Fan, W., Zhou, X., Zeng, L., Guo, Y., Kou, Z., Yu, H., Li, J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu887 · Cited by 83
von Willebrand factor is a cofactor in complement regulation
Feng, S., Liang, X., Kroll, M. H., et al. (2014) · Blood · doi:10.1182/blood-2014-06-585430 · Cited by 82
Complement’s hidden arsenal: New insights and novel functions inside the cell
Liszewski, M. K., Elvington, M. L., Kulkarni, H. S., & Atkinson, J. P. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.004 · Cited by 80
Self-citationInterferon-complement loop in transplant-associated thrombotic microangiopathy
Jodele, S., Medvedovic, M., Luebbering, N., Chen, J., Dandoy, C. E., Laskin, B. L., & Davies, S. M. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001515 · Cited by 74
Urine proteome of COVID-19 patients
(2020) · doi:10.1016/j.urine.2021.02.001 · Cited by 68
Deficient IFN Signaling by Myeloid Cells Leads to MAVS-Dependent Virus-Induced Sepsis
Pinto, A. K., Ramos, H. J., Wu, X., Aggarwal, S., Shrestha, B., Gorman, M., Kim, K. Y., Suthar, M. S., Atkinson, J. P., Gale Jr, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004086 · Cited by 67
Self-citationPreece, A. F., Strahan, K. M., Devitt, J., Yamamoto, F.-I., & Gustafsson, K. (2002) · Blood · doi:10.1182/blood.v99.7.2477 · Cited by 66
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation
Ueda, Y., Mohammed, I., Song, D., Gullipalli, D., Zhou, L., Sato, S., Wang, Y., Gupta, S., Cheng, Z. A., Wang, H., et al. (2017) · Blood · doi:10.1182/blood-2016-07-728253 · Cited by 64
Bettoni, S., Galbusera, M., Gastoldi, S., Donadelli, R., Tentori, C., Spartà, G., Bresin, E., Mele, C., Alberti, M., Tortajada, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601121 · Cited by 63
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Riedemann, N. C., Habel, M., Ziereisen, J., Hermann, M., Schneider, C., Wehling, C., Kirschfink, M., Kentouche, K., & Guo, R. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.012 · Cited by 51
Safety profile after prolonged C3 inhibition
Reis, E. S., Berger, N., Wang, X., Koutsogiannaki, S., Doot, R. K., Gumas, J. T., Foukas, P. G., Resuello, R. R. G., Tuplano, J. V., Kukis, D. L., et al. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.09.004 · Cited by 47
Ito, S., Hidaka, Y., Inoue, N., Kaname, S., Kato, H., Matsumoto, M., Miyakawa, Y., Mizuno, M., Okada, H., Shimono, A., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1610-2 · Cited by 46
Development and Optimization of an ELISA to Quantitate C3(H2O) as a Marker of Human Disease
Elvington, M. L., Liszewski, M. K., Liszewski, A. R., Kulkarni, H. S., Hachem, R. R., Mohanakumar, T., Kim, A. H. J., & Atkinson, J. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00703 · Cited by 33
Self-citationLiszewski, M. K., Bertram, P. G., Leung, M. K., Hauhart, R. E., Zhang, L., & Atkinson, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4199 · Cited by 32
Self-citationTreatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application*
Sun, S., Jiang, Y., Wang, R., Liu, C., Liu, X., Song, N., Guo, Y., Guo, R., Du, L., Jiang, S., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002950 · Cited by 29
Kato, H., Miyakawa, Y., Hidaka, Y., Inoue, N., Ito, S., Kagami, S., Kaname, S., Matsumoto, M., Mizuno, M., Matsuda, T., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1609-8 · Cited by 28
Editorial: Natural Antibodies in Health and Disease
Hernández, A., & Holodick, N. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01795 · Cited by 12
Ramlall, V., Thangara, P. M., Tatonetti, N. P., & Shapira, S. D. (2020) · doi:10.21203/rs.3.rs-26451/v1 · Cited by 8
Cited by
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D. C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., Tsigalou, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141374 · Cited by 786
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 418
Yu, J., Yuan, X., Chen, H., Chaturvedi, S., Braunstein, E. M., & Brodsky, R. A. (2020) · Blood · doi:10.1182/blood.2020008248 · Cited by 374
A guide to complement biology, pathology and therapeutic opportunity
Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00926-1 · Cited by 320
Metadata
- Authors
- Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S.
- Venue
- JCI Insight
- Published
- 2020-08-06
- Volume
- 5
- Issue
- 15
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W3036101703
- Cited by
- 376
- References
- 113
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.